CVS Health Corp (CVS) Earnings: Maintains FY Adjusted EPS Forecast; Senior Management to Meet Investors

Cvs Health Corp on Smartkarma

Baptista Research, an independent investment research network, recently published two research reports on CVS Health Corp. The first report, titled “CVS Health Corporation: 5 Key Growth Factors Every Investor Must Know! – Major Drivers“, reported that CVS Health Corporation exceeded the revenue and earnings expectations of Wall Street, and that acquisitions of Signify Health and Oak Street Health have strengthened its position in value-based care. The report gave CVS Health Corporation a “Buy” rating with a revised target price.

The second report, titled “CVS Health Corporation: Does The Signify Acquisition Make It A Sureshot Buy? – Key Drivers“, reported that CVS Health Corporation performed well in terms of revenue growth, operating cash flow, and adjusted profits per share. However, the company anticipates decreases for the remainder of the year as the public health emergency ends.

A look at Cvs Health Corp Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

CVS Health Corporation is an integrated pharmacy health care provider with drugstores throughout the United States, the District of Columbia, and Puerto Rico. According to Smartkarma Smart Scores, the long-term outlook for CVS Health Corp looks positive, with a score of 4 for Value, 3 for Dividend, 3 for Growth, 2 for Resilience, and 3 for Momentum. This indicates that the company is likely to remain strong in the long-term, providing quality services, steady dividends, and a resilient business model.

CVS Health Corp is committed to providing quality services to its customers and is likely to remain a leader in the health care industry in the long-term. With a score of 4 for Value, 3 for Dividend, and 3 for Growth, the company is well-positioned to stay competitive and profitable in the future. Additionally, its score of 2 for Resilience is an indication of its commitment to weathering economic and industry challenges.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma